Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response

Cellular Microbiology

Volumn 15, Issue 1, 2013, Pages 98-113

  Guidi, Riccardo ^a   Guerra, Lina ^a   Levi, Laura ^a   Stenerlöw, Bo ^b   Fox, James G ^c   Josenhans, Christine ^d   Masucci, Maria G ^a   Frisan, Teresa ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CELL CYCLE; CELL SURVIVAL; CHROMATIN; CHROMOSOME ABERRATION; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA REPAIR; EPITHELIUM CELL; FIBROBLAST; GENE MUTATION; GENOMIC INSTABILITY; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE;

ANIMALS; BACTERIAL TOXINS; CELL LINE; CELL SURVIVAL; DNA DAMAGE; EPITHELIAL CELLS; FIBROBLASTS; GENOMIC INSTABILITY; GRAM-NEGATIVE BACTERIA; HUMANS; MUTAGENS; RATS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 84871078633     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12034     Document Type: Article

References (75)

1. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., etal. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
2. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., etal. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
3. Candela, M., Guidotti, M., Fabbri, A., Brigidi, P., Franceschi, C., and Fiorentini, C. (2011) Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol 37: 1-14.
4. Carvalho, F.A., Aitken, J.D., Vijay-Kumar, M., and Gewirtz, A.T. (2011) Toll-like receptor-gut microbiota interactions: perturb at your own risk! Annu Rev Physiol 74: 177-198.
5. Cheng, K.C., Cahill, D.S., Kasai, H., Nishimura, S., and Loeb, L.A. (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions. J Biol Chem 267: 166-172.
6. Chien, C.C., Taylor, N.S., Ge, Z., Schauer, D.B., Young, V.B., and Fox, J.G. (2000) Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 49: 525-534.
7. Ciccia, A., and Elledge, S.J. (2010) The DNA damage response: making it safe to play with knives. Mol Cell 40: 179-204.
8. Cortes-Bratti, X., Karlsson, C., Lagergard, T., Thelestam, M., and Frisan, T. (2001) The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J Biol Chem 276: 5296-5302.
9. Cuevas-Ramos, G., Petit, C.R., Marcq, I., Boury, M., Oswald, E., and Nougayrede, J.P. (2010) Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 107: 11537-11542.
10. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., etal. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
11. DuPont, A.W., and DuPont, H.L. (2011) The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 8: 523-531.
12. Dutta, U., Garg, P.K., Kumar, R., and Tandon, R.K. (2000) Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 95: 784-787.
13. Elwell, C., Chao, K., Patel, K., and Dreyfus, L. (2001) Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect Immun 69: 3418-3422.
14. Feagins, L.A., Souza, R.F., and Spechler, S.J. (2009) Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 6: 297-305.
15. Fenton, J.I., Hursting, S.D., Perkins, S.N., and Hord, N.G. (2006) Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line. Carcinogenesis 27: 1507- 1515.
16. Fox, J.G., Rogers, A.B., Whary, M.T., Ge, Z., Taylor, N.S., Xu, S., etal. (2004) Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C.jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun 72: 1116-1125.
17. Frisan, T., Cortes-Bratti, X., Chaves-Olarte, E., Stenerlöw, B., and Thelestam, M. (2003) The Haemophilus ducreyi cytolethal distending toxin induces DNA double strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol 5: 695-707.
18. Ge, Z., Feng, Y., Whary, M.T., Nambiar, P.R., Xu, S., Ng, V., etal. (2005) Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect Immun 73: 3559-3567.
19. Ge, Z., Rogers, A.B., Feng, Y., Lee, A., Xu, S., Taylor, N.S., and Fox, J.G. (2007) Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 9: 2070-2080.
20. Gout, S., Morin, C., Houle, F., and Huot, J. (2006) Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 66: 9117-9124.
21. Greten, F.R., Eckmann, L., Greten, T.F., Park, J.M., Li, Z.W., Egan, L.J., etal. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
22. Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.Y., Vallabhapurapu, S., etal. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.
23. Grivennikov, S.I., Greten, F.R., and Karin, M. (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
24. Guerra, L., Teter, K., Lilley, B.N., Stenerlow, B., Holmes, R.K., Ploegh, H.L., etal. (2005) Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol 7: 921-934.
25. Guerra, L., Carr, H.S., Richter-Dahlfors, A., Masucci, M.G., Thelestam, M., Frost, J.A., and Frisan, T. (2008) A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage. PLoS ONE 3: e2254.
26. Guerra, L., Guidi, R., and Frisan, T. (2011a) Do bacterial genotoxins contribute to chronic inflammation, genomic instability and tumor progression? FEBS J 278: 4577-4588.
27. Guerra, L., Cortes-Bratti, X., Guidi, R., and Frisan, T. (2011b) The biology of the cytolethal distending toxins. Toxins (Basel) 3: 172-190.
28. Guma, M., Stepniak, D., Shaked, H., Spehlmann, M.E., Shenouda, S., Cheroutre, H., etal. (2011) Constitutive intestinal NF-kappaB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med 208: 1889-1900.
29. Habraken, Y., Jolois, O., and Piette, J. (2003) Differential involvement of the hMRE11/hRAD50/NBS1 complex, BRCA1 and MLH1 in NF-kappaB activation by camptothecin and X-ray. Oncogene 22: 6090-6099.
30. Halazonetis, T.D., Gorgoulis, V.G., and Bartek, J. (2008) An oncogene-induced DNA damage model for cancer development. Science 319: 1352-1355.
31. Hanahan, D., and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
32. Hassane, D.C., Lee, R.B., and Pickett, C.L. (2003) Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cells. Infect Immun 71: 541-545.
33. He, G., and Karin, M. (2011) NF-kappaB and STAT3 - key players in liver inflammation and cancer. Cell Res 21: 159-168.
34. He, G., Yu, G.Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., etal. (2010) Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 17: 286-297.
35. Honda, K., and Littman, D.R. (2012) The microbiome in infectious disease and inflammation. Annu Rev Immunol 30: 759-795.
36. Hoyes, K.P., Wadeson, P.J., Sharma, H.L., Hendry, J.H., and Morris, I.D. (1998) Mutation studies in lacI transgenic mice after exposure to radiation or cyclophosphamide. Mutagenesis 13: 607-612.
37. Ikehata, H., and Ono, T. (2011) The mechanisms of UV mutagenesis. J Radiat Res 52: 115-125.
38. Karin, M., Lawrence, T., and Nizet, V. (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124: 823-835.
39. Kim, J.J., Tao, H., Carloni, E., Leung, W.K., Graham, D.Y., and Sepulveda, A.R. (2002) Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 123: 542-553.
40. Kim, S.I., Pfeifer, G.P., and Besaratinia, A. (2007) Mutagenicity of ultraviolet A radiation in the lacI transgene in Big Blue mouse embryonic fibroblasts. Mutat Res 617: 71-78.
41. Kishimoto, T. (2005) Interleukin-6: from basic science to medicine - 40 years in immunology. Annu Rev Immunol 23: 1-21.
42. Lara-Tejero, M., and Galan, J.E. (2000) A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290: 354-357.
43. Lara-Tejero, M., and Galan, J.E. (2001) CdtA, CdtB and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect Immun 69: 4358-4365.
44. Leung, W.K., Kim, J.J., Kim, J.G., Graham, D.Y., and Sepulveda, A.R. (2000) Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 156: 537-543.
45. Li, L., Sharipo, A., Chaves-Olarte, E., Masucci, M.G., Levitsky, V., Thelestam, M., and Frisan, T. (2002) The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol 4: 87-99.
46. Loeb, L.A., Bielas, J.H., and Beckman, R.A. (2008) Cancers exhibit a mutator phenotype: clinical implications. Cancer Res 68: 3551-3557; discussion 3557.
47. Lorimore, S.A., Coates, P.J., and Wright, E.G. (2003) Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 22: 7058-7069.
48. McSweeney, L.A., and Dreyfus, L.A. (2004) Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell Microbiol 6: 447-458.
49. McSweeney, L.A., and Dreyfus, L.A. (2005) Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits. Infect Immun 73: 2051-2060.
50. Mahendran, V., Riordan, S.M., Grimm, M.C., Tran, T.A., Major, J., Kaakoush, N.O., etal. (2011) Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS ONE 6: e25417.
51. Maloy, K.J., and Powrie, F. (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474: 298-306.
52. Martinez, I., Mateo, E., Churruca, E., Girbau, C., Alonso, R., and Fernandez-Astorga, A. (2006) Detection of cdtA, cdtB, and cdtC genes in Campylobacter jejuni by multiplex PCR. Int J Med Microbiol 296: 45-48.
53. Negrini, S., Gorgoulis, V.G., and Halazonetis, T.D. (2010) Genomic instability - an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220-228.
54. Nelson, S.L., Parks, K.K., and Grosovsky, A.J. (1996) Ionizing radiation signature mutations in human cell mutants induced by low-dose exposures. Mutagenesis 11: 275-279.
55. Nesic, D., Hsu, Y., and Stebbins, C.E. (2004) Assembly and function of a bacterial genotoxin. Nature 429: 429-433.
56. de Oliveira, M.F., Amoedo, N.D., and Rumjanek, F.D. (2012) Energy and redox homeostasis in tumor cells. Int J Cell Biol 2012: 593838.
57. Park, D.I., Park, S.H., Kim, S.H., Kim, J.W., Cho, Y.K., Kim, H.J., etal. (2005) Effect of Helicobacter pylori infection on the expression of DNA mismatch repair protein. Helicobacter 10: 179-184.
58. Pickett, C.L., Pesci, E.C., Cottle, D.L., Russell, G., Erdem, A.N., and Zeytin, H. (1996) Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect Immun 64: 2070-2078.
59. Pikarsky, E., Porat, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., etal. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466.
60. Plottel, C.S., and Blaser, M.J. (2011) Microbiome and malignancy. Cell Host Microbe 10: 324-335.
61. Rakoff-Nahoum, S., and Medzhitov, R. (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124-127.
62. Rakoff-Nahoum, S., and Medzhitov, R. (2009) Toll-like receptors and cancer. Nat Rev Cancer 9: 57-63.
63. Ripabelli, G., Tamburro, M., Minelli, F., Leone, A., and Sammarco, M.L. (2010) Prevalence of virulence-associated genes and cytolethal distending toxin production in Campylobacter spp. isolated in Italy. Comp Immunol Microbiol Infect Dis 33: 355-364.
64. Sankaranarayanan, K. (1991) Ionizing radiation and genetic risks. III. Nature of spontaneous and radiation-induced mutations in mammalian in vitro systems and mechanisms of induction of mutations by radiation. Mutat Res 258: 75-97.
65. Scott, D.A., and Kaper, J.B. (1994) Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxins. Infect Immun 62: 244-251.
66. Sekiguchi, M., and Tsuzuki, T. (2002) Oxidative nucleotide damage: consequences and prevention. Oncogene 21: 8895-8904.
67. Silke, J. (2011) The regulation of TNF signalling: what a tangled web we weave. Curr Opin Immunol 23: 620-626.
68. Storz, P. (2005) Reactive oxygen species in tumor progression. Front Biosci 10: 1881-1896.
69. Touati, E. (2010) When bacteria become mutagenic and carcinogenic: lessons from H.pylori. Mutat Res 703: 66-70.
70. Touati, E., Michel, V., Thiberge, J.M., Wuscher, N., Huerre, M., and Labigne, A. (2003) Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 124: 1408-1419.
71. Vogelmann, R., and Amieva, M.R. (2007) The role of bacterial pathogens in cancer. Curr Opin Microbiol 10: 76-81.
72. Wagner, E.F., and Nebreda, A.R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
73. Watson, D.E., Cunningham, M.L., and Tindall, K.R. (1998) Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts. Mutagenesis 13: 487-497.
74. Winegar, R.A., Lutze, L.H., Hamer, J.D., O'Loughlin, K.G., and Mirsalis, J.C. (1994) Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice. Mutat Res 307: 479-487.
75. Yang, S.Y., Miah, A., Sales, K.M., Fuller, B., Seifalian, A.M., and Winslet, M. (2011) Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment. Int J Oncol 38: 1695-1702.